Merck Continues to Face Revenue Challenges
ThinkstockDrug giant Merck & Co. Inc. (NYSE: MRK) reported third-quarter 2013 results before markets opened Monday morning. The company posted adjusted diluted earnings per share (EPS) of $0.92 and revenues of $11.03 billion. In…